At the peak of the madness, Moderna hit a PE of 100+ with stock price soaring to 450$
Now its at a humble 120$ with the PE ratio of only 3-5. At this PE ratio, this seems like a no brainer stock. Moderna is no longer a “one trial will end us” company, and is on its way to becoming medium size pharma.
So at this PE it looks more attractive than PE 20+ for Pfizer.
What are the downsides to MRNA as a medium/long term hold?
Consensus on this stock is Neutral. whats going on?
Leave a Reply